Daniel Abdun-Nabi, President at Emergent BioSolutions Inc. (EBS), sold 11,000 shares at $17.43 ($189K) on 2009-08-11, disclosed to the SEC on 2009-08-13.
Open-market sale of $189k EBS by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.09 | 4,800 | $82K | 43.3% |
| 2 | $17.11 | 500 | $9K | 4.5% |
| 3 | $17.13 | 500 | $9K | 4.5% |
| 4 | $17.15 | 200 | $3K | 1.8% |
| 5 | $17.18 | 500 | $9K | 4.5% |
| 6 | $17.20 | 100 |
| $2K |
| 0.9% |
| 7 | $17.21 | 500 | $9K | 4.5% |
| 8 | $17.22 | 100 | $2K | 0.9% |
| 9 | $17.31 | 300 | $5K | 2.7% |
| 10 | $17.34 | 100 | $2K | 0.9% |
| 11 | $17.38 | 600 | $10K | 5.5% |
| 12 | $17.40 | 1,100 | $19K | 10.1% |
| 13 | $17.43 | 200 | $3K | 1.8% |
| 14 | $17.45 | 700 | $12K | 6.4% |
| 15 | $17.53 | 200 | $4K | 1.9% |
| 16 | $17.57 | 300 | $5K | 2.8% |
| 17 | $17.61 | 300 | $5K | 2.8% |
| Total | $17.23 avg | 11,000 | $189K | 100% |
| Filing → |
| EBS | SELL | 2018-09-18 | $1.9M | — | Filing → |
| EBS | SELL | 2018-09-06 | $5.5M | — | Filing → |
| EBS | SELL | 2018-06-07 | $823K | — | Filing → |